mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.085 |
0.01 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.02 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.02 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.02 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.02 |
mRNA |
AP-24534 |
GDSC1000 |
pan-cancer |
AAC |
0.08 |
0.02 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.02 |